Patents by Inventor Sergio Anzalone

Sergio Anzalone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of amtolmetin guacyl for the production of anti-inflammatory drugs for intestinal inflammations
    Patent number: 6495590
    Abstract: The present invention relates to the use of amtolmetin guacyl for the production of an anti-inflammatory drug for intestinal inflammations. Furthermore, the uses of amtolmetin guacyl for the treatment of thrombophlebitis, as anti-platelet agent and for anti-inflammatory and antalgic treatment, particularly in the case of infracted subjects and of subjects suffering from an ictus of thrombotic type are disclosed.
    Type: Grant
    Filed: October 1, 2001
    Date of Patent: December 17, 2002
    Assignees: Medosan Ricerca S.r.l., Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventor: Sergio Anzalone
  • Crystalline polymorphic form of 1-methyl-5-p-toluoylpyrrple-2-acetamidoacetic acid guaiacyl ester (MED 15)
    Patent number: 6288241
    Abstract: A new crystalline form of 1-methyl-5-p-toluoylpyrrole-2-acetamidoacetic acid guaiacyl ester, a process for its preparation and pharmaceutical compositions endowed of anti-inflammatory, analgesic and antipyretic activity containing same are disclosed.
    Type: Grant
    Filed: June 12, 2000
    Date of Patent: September 11, 2001
    Assignee: Sigma-Tau Farmaceutiche Riunite S.p.A.
    Inventor: Sergio Anzalone
  • Method for counteracting blood platelet aggregation in a patient in need thereof
    Patent number: 6180658
    Abstract: The present invention relates to A method for counteracting blood platelet aggregation in a patient in need thereof and in need of a treatment of pain and inflammation, comprising administering (on an empty stomach) an amount of 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamido acetate effective to treat pain and inflammation and to avoid platelet aggregation. The present invention relates further to a method for treating trombophlebitis and pain and inflammation in an infarct patient or in a patient suffering by or under risk of cerebral stroke of thrombotic origin comprising administering on empty stomach an anti-inflammatory effective amount of 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamido acetate (known also as amtolmetin guacyl and indicated in the present description also as MED 15).
    Type: Grant
    Filed: October 30, 1998
    Date of Patent: January 30, 2001
    Assignee: Medosan Ricerca S.r.l.
    Inventor: Sergio Anzalone
  • Method for treating an inflammatory pathological condition
    Patent number: 5889041
    Abstract: The present invention relates to a method for treating an inflammatory pathological condition in a patient in need thereof, comprising administering on empty stomach an anti-inflammatory effective amount of 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamido acetate (known also as amtolmetin guacyl and indicated in the present description also as MED 15).
    Type: Grant
    Filed: August 6, 1997
    Date of Patent: March 30, 1999
    Assignee: MEDOSAN Ricerca S.r.l.
    Inventor: Sergio Anzalone
  • Method for treating an inflammatory condition with prevention of secretive activity of gastric secretive level
    Patent number: 5866600
    Abstract: A method for treating an inflammatory pathological condition with simultaneous prevention of a secretive activity on gastric secretion comprising the step of administering a subject in need thereof an effective amount of 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2acetamido acetate.
    Type: Grant
    Filed: July 15, 1996
    Date of Patent: February 2, 1999
    Assignee: Medosan Ricerca S.R.L.
    Inventor: Sergio Anzalone
  • Diethylaminoethyl dextran for decreasing hyperglycemia
    Patent number: 4810696
    Abstract: Diethylaminoethyl dextran (DEAE-D) has an activity for decreasing hyperglycemia, leading to an improved balance of the glucosic metabolism and can be usefully administered to diabetics.
    Type: Grant
    Filed: June 26, 1987
    Date of Patent: March 7, 1989
    Assignee: Medosan Indusrie Biochemiche Riunite S.p.A
    Inventor: Sergio Anzalone